Financials

News Discussions

BRETECN0125 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to BIORETEC OY NEW SHARE operating, investing, and financing activities

BRETECN0125 free cash flow for H2 24 is -3.61 M EUR. For 2024, BRETECN0125 free cash flow was -6.37 M EUR and operating cash flow was -5.64 M EUR.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—